Pharma

Pharma M&A deals decline in 2017 amid challenging business climate

“There is interest from Indian companies to acquire assets overseas, across generic and specialty segment. Most players can be seen to bid for available assets though they are looking for the right fit in terms of product portfolio and geography,”

Vrinda Mathur
Partner, Grant Thornton India LLP

This article appeared in Live Mint on 18th October, 2017.